Jeryl Lynn Hilleman
Independent DirectorMs. Jeryl Lynn Hilleman, also known as Jeri, is Board Member of Reiter Affiliated Companies, LLC. Ms. Hilleman has been an Independent Director at HilleVax, Inc since April 2021. She served as Director of Cutera, Inc. from July 12, 2024 until February 12, 2025. She served as an Independent Director at Talis Biomedical Corporation since March 2021 until April 20, 2022. Ms. Hilleman has executive leadership and financial experience. She serves as Chairman of the Board of Omada Health, Inc. since July 2020 and has been its Director since April 2019 and also serves as its Lead Director. She serves as Independent Director at Cardiva Medical, Inc. since January 2020. She is Independent Director of NovoCure Limited since July 25, 2018. She had been Advisor of Intersect ENT, Inc. since November 2019 until 2020. She was the Chief Financial Officer of Intersect ENT, Inc. since June 2014 until December 2019. She serves as an Independent Director of SI-BONE, Inc., since December 3, 2019. She joined the SI-BONE, Inc. on December 03, 2019. She served as the Chief Financial Officer and Secretary of Ocera Therapeutics, Inc. from September 3, 2013 to June 3, 2014 and as its Principal Accounting Officer since December 11, 2013. She served as the Chief Financial Officer of Amyris, Inc., (formerly, Amyris Biotechnologies, Inc.) from January 2008 to May 2012 and also served as its Principal Accounting Officer, where she was responsible for managing Amyris’ financial and accounting operations. She also served as Advisor of Symyx Technologies Inc. until July 2010. She served as the Chief Financial Officer of Symyx Technologies Inc., from June 1997 to June 1, 2007 and also served as its Principal Accounting Officer and Secretary. She served as Executive Vice President of Symyx Technologies Inc., until June 1, 2007. From 2012 to 2013, Ms. Hilleman provided independent financial and strategic consulting for biotech and cleantech companies. Ms. Hilleman has experience and a strong background in arranging financing and facilitating rapid growth for both biotechnology and energy industry startups. She served as Senior Vice President of Symyx Technologies Inc., since August 1999 and its Vice President from June 1997 to August 1999. Prior to joining Symyx Technologies Inc. in 1997, Ms. Hilleman served as Vice President of Finance and Chief Financial Officer of two public biotechnology companies, Geron Corporation and Cytel Corporation. She served as a Vice President of Cytel Corporation. She was the second employee and Vice President at Geron Corporation. She was Independent Director of Minerva Neurosciences, Inc. since July 16, 2018 until August 6, 2024. She served as an Independent Director at Xenoport, Inc. from January 2005 to July 5, 2016. She was selected as a 1999 Crown Fellow by the Aspen Institute. She holds an A.B. in History from Brown University and an M.B.A. from the Wharton School at the University of Pennsylvania.
Positions
- Company NameSI-BONE, Inc.Stock CodeSIBNPositionIndependent DirectorColleagues
- JWJeffrey W. DunnExecutive Chairman
- LALaura A. FrancisCEO & Director
- AMAnshul MaheshwariCOO & CFO
- MAMichael A. PisetskyChief Business & Legal Affairs Officer, Secretary and General Counsel
- AJAnthony J. RecuperoAdvisor
- TETimothy E. DavisLead Independent Director
- JLJeryl Lynn HillemanIndependent Director
- MNMika NishimuraIndependent Director
- Company NameNovoCure LimitedStock CodeNVCRPositionIndependent DirectorColleagues
- WFWilliam F. DoyleExecutive Chairman
- FLFrank LeonardCEO & Director
- CBChristoph BrackmannChief Financial Officer
- MPMichael PuriChief Human Resources Officer
- UWUri WeinbergChief Innovation Officer & Chief Medical Officer
- KGKinyip Gabriel LeungIndependent Director
- MJMartin J. MaddenIndependent Director
- JLJeryl Lynn HillemanIndependent Director
- Company NameOmada Health, Inc.Stock CodeOMDAPositionIndependent Chairperson & Lead DirectorColleagues
- SPSean P. DuffyCo-Founder, CEO & Director
- WSWei-Li ShaoPresident
- SLSteven L. CookChief Financial Officer
- LFLauren FixSenior Vice President of Corporate Strategy & Operations
- CGCraig GraceyChief Accounting Officer
- TFTrevor FetterIndependent Director
- JDJonathan D. RootIndependent Director
- ASAdam StaviskyIndependent Director
